Immunotherapy drugs are riskier for treatment of cancer patients, study suggests – Devdiscourse

A study published in the European Heart Journal, found that the risks of heart problems in cancer patients are higher if they are treated with immunotherapy drugs, which can even lead to death from heart attack. The researchers from Department of Cardiology at Herlev og Gentofte Hospital, Hellerup, Denmark revealed that the patients diagnosed with either lung cancer or malignant melanoma (a type of skin cancer), are treated with immune checkpoint inhibitors such as a programmed cell death-1 (PD1)…

Click here to view the original article.